Indianapolis, IN – Hammond, Kennedy, Whitney & Company, Inc. (“HKW”) announced that it closed on the recapitalization of GMD Distribution Inc. and Ophthalmic Direct LP (collectively “GMD” or “Company”) on March 24, 2015. GMD, headquartered in Oakville, Ontario, Canada, is a leading distributor to the pharmaceutical industry and specializes in supplying specialty ophthalmic pharmaceuticals to clinics across Canada. GMD develops customized programs for a variety of clients that enable the direct distribution of pharmaceuticals and other healthcare products to Canadian pharmacies and clinics. For additional information on the Company, please visit https://www.gmdpharma.ca/.
John Leombruno, CEO of GMD stated, “HKW’s partnership mentality and experience in the Canadian healthcare industry was appealing to the GMD shareholders. The management team looks forward to further expanding the Company alongside HKW, an empowering and experienced financial partner.”
“GMD has become a niche market leader in the Canadian pharmaceutical industry through a combination of excellent management and tremendous customer service,” said Glenn Scolnik, HKW Chairman. “John Leombruno, Kabeer Baig and the rest of the GMD team are talented, driven executives that are a great fit with our investment criteria. We look forward to a successful partnership.” John Carsello, HKW Partner added “The opportunity to support an experienced management team and invest in GMD, which serves growing markets such as age-related macular degeneration and diabetic macular edema, was highly attractive to HKW.”
GMD and OD were represented by NewPoint Capital Partners and CCC Investment Banking in this transaction.
About HKW – HKW is a private equity firm founded in 1903 with offices in Indianapolis and New York. Since 1982, HKW has sponsored 48 platform transactions of lower middle-market companies throughout North America, as well as 52 add-on acquisitions. For further information on HKW, please visit www.hkwinc.com.